The short answer
High-dose vitamin E supplements warrant a bleeding precaution with heparin, but a change in heparin absorption or measured anticoagulant potency has not been established. Food intake is a different exposure from high-dose supplementation.
What this answer covers
Oral supplemental vitamin E, primarily alpha-tocopherol evidence, with injected unfractionated heparin; not vitamin E-coated dialysis membranes or topical combination creams.
- Supplement or preparation
- Vitamin E
- Medication ingredient
- heparin
The concern is clotting, not gut absorption
Federal guidance warns that large vitamin E doses may increase bleeding with anticoagulants. Heparin is injected because it is not absorbed from the digestive tract. The vitamin E warning therefore does not demonstrate altered heparin absorption.
Other anticoagulants provide limited comparisons
A small trial in 21 warfarin-treated patients found no significant INR change with vitamin E. Warfarin and heparin work differently, and INR is not a substitute for heparin-specific bleeding outcomes. This null result neither proves heparin safety nor establishes increased heparin potency.
Dose and form matter
The exact supplement amount and form should be reviewed. NIH guidance does not give a certain clinically significant interaction threshold, and dietary vitamin E is not equivalent to concentrated supplements. A suggested threshold should not be treated as a guaranteed safe boundary.
Keep the clinical team informed
Tell the heparin team about the exact supplement before starting or changing it. Report unusual bleeding or bruising promptly; serious bleeding, black stools or vomiting blood needs urgent assessment. Do not change prescribed heparin yourself. Do not alter heparin to accommodate vitamin E, and do not rely on a short gap between doses to prevent a possible clotting effect.
Evidence and practical considerations
Absorption & effectiveness
No measured change in heparin action or exposure. Injected heparin does not depend on gastrointestinal absorption; warfarin INR data cannot establish this claim.
- Exact scope
- Oral supplemental vitamin E, primarily alpha-tocopherol evidence, with injected unfractionated heparin; not vitamin E-coated dialysis membranes or topical combination creams. with Unfractionated heparin sodium intravenous/subcutaneous, active-ingredient bridge to RxCUI5224 IN. Not LMWH or topical therapy.
- Medication form and route
- intravenous or subcutaneous unfractionated heparin; oral supplement
What remains uncertain
- No universal risk estimate, dose adjustment or spacing interval; source-specific limits apply.
Factors that may matter: Exact product; Dose/duration; Other antithrombotics; Bleeding risk; Kidney function.
Read the supporting source summaries
Source 1: current product label
dailymed.nlm.nih.gov · Source check Sep 10, 2026
Population: People receiving parenteral unfractionated heparin.
Heparin can cause hemorrhage; medicines inhibiting platelets can add bleeding concerns. Aldosterone suppression can cause hyperkalemia, especially with predisposing conditions or potassium-sparing medicines. Heparin is not absorbed through the gastrointestinal tract.
How this applies: Exact species, preparation, route and measured endpoints govern applicability; other anticoagulants are not silently treated as heparin.
No botanical interaction specifically named. Not low-molecular-weight heparin, topical heparin cream or an oral anticoagulant; doses and risks of catheter flush products are not automatically equivalent.
Source 2: regulatory guidance
ods.od.nih.gov · Source check Sep 10, 2026
Population: Users of the specified preparation.
Large supplemental doses may increase bleeding with anticoagulants or antiplatelets; clinically significant dose threshold is uncertain.
How this applies: Exact species, preparation, route and measured endpoints govern applicability; other anticoagulants are not silently treated as heparin.
Warfarin-related vitamin K explanation is not a heparin absorption mechanism; guidance does not measure this exact pair.
Source 3: original human study
pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026
Population: 21 warfarin-treated patients.
No significant INR change with vitamin E versus placebo.
How this applies: Exact species, preparation, route and measured endpoints govern applicability; other anticoagulants are not silently treated as heparin.
21 subjects, surrogate INR endpoint, not heparin and not proof of no bleeding at any dose. Dose not supplied in inspected abstract.
Research assessment: · Open full citations ↗
Side effects & toxicity
Indirect high-dose supplement/anticoagulant bleeding precaution, without a verified heparin dose-response or universal dietary effect.
- Exact scope
- Oral supplemental vitamin E, primarily alpha-tocopherol evidence, with injected unfractionated heparin; not vitamin E-coated dialysis membranes or topical combination creams. with Unfractionated heparin sodium intravenous/subcutaneous, active-ingredient bridge to RxCUI5224 IN. Not LMWH or topical therapy.
- Medication form and route
- intravenous or subcutaneous unfractionated heparin; oral supplement
What remains uncertain
- No universal risk estimate, dose adjustment or spacing interval; source-specific limits apply.
Factors that may matter: Exact product; Dose/duration; Other antithrombotics; Bleeding risk; Kidney function.
Read the supporting source summaries
Source 1: current product label
dailymed.nlm.nih.gov · Source check Sep 10, 2026
Population: People receiving parenteral unfractionated heparin.
Heparin can cause hemorrhage; medicines inhibiting platelets can add bleeding concerns. Aldosterone suppression can cause hyperkalemia, especially with predisposing conditions or potassium-sparing medicines. Heparin is not absorbed through the gastrointestinal tract.
How this applies: Exact species, preparation, route and measured endpoints govern applicability; other anticoagulants are not silently treated as heparin.
No botanical interaction specifically named. Not low-molecular-weight heparin, topical heparin cream or an oral anticoagulant; doses and risks of catheter flush products are not automatically equivalent.
Source 2: regulatory guidance
ods.od.nih.gov · Source check Sep 10, 2026
Population: Users of the specified preparation.
Large supplemental doses may increase bleeding with anticoagulants or antiplatelets; clinically significant dose threshold is uncertain.
How this applies: Exact species, preparation, route and measured endpoints govern applicability; other anticoagulants are not silently treated as heparin.
Warfarin-related vitamin K explanation is not a heparin absorption mechanism; guidance does not measure this exact pair.
Source 3: original human study
pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026
Population: 21 warfarin-treated patients.
No significant INR change with vitamin E versus placebo.
How this applies: Exact species, preparation, route and measured endpoints govern applicability; other anticoagulants are not silently treated as heparin.
21 subjects, surrogate INR endpoint, not heparin and not proof of no bleeding at any dose. Dose not supplied in inspected abstract.
Research assessment: · Open full citations ↗
Review and change history
- Publication status
- Published research summary
- Clinical review
- Not yet recorded
| Date | Update |
|---|---|
| Article prepared | |
| Prepared exact-pair article preserving route, formulation, clinical-outcome and laboratory-endpoint distinctions. | |
| Research summary published |
Article revision: cb9533eb3aa14c3b
This guide brings together the evidence records used by our interaction checker. Each finding retains its own preparation limits, research date, and source summaries.
Full citations require verification. Reading this answer and the source summaries does not.
Taking other supplements or medications?
Use the checker to explore your other combinations. Ask a pharmacist to review the exact products, amounts and medical conditions in your complete list.
Open the interaction checkerInformation, not medical advice. Do not change prescribed treatment based on this guide.